Contrast-enhanced Mammography for Breast Cancer Screening in Women at Increased Risk: Comparison of Prevalence and Incidence Screens
Authors:
- Carol H. LeeCLCarol H. Lee
- Tali AmirTATali Amir
- Varadan SevilimeduVSVaradan Sevilimedu
- Sarah Eskreis-WinklerSESarah Eskreis-Winkler
- Donna D’ALessioDDDonna D’ALessio
- Maxine S. JochelsonMJMaxine S. Jochelson
- Gordon P. WattGWGordon P. Watt
- Kimberly N. FeiginKFKimberly N. Feigin
- Noam NissanNNNoam Nissan
- Hila Fruchtman-BrotHFHila Fruchtman-Brot
- Christopher E. ComstockCCChristopher E. Comstock
- 1 July 2026
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (1)
Abstract
The ability of contrast-enhanced mammography to help detect cancer during prevalence screening in women at increased risk for breast cancer is maintained in subsequent incidence screens, with better specificity and accuracy.Keywords
Funding Information
- National Institutes of Health (CA008748)
- National Cancer Institute (CA008748)
This publication has 32 references indexed in Scilit:
- Evaluating ten years of breast cancer screening with contrast enhanced mammography in women with Intermediate-high riskEuropean Journal of Radiology, 2024
- Contrast-enhanced mammography for surveillance in women with a personal history of breast cancerBreast Cancer Research and Treatment, 2024
- Brief communication: The current status of contrast-enhanced mammography in breast imagingClinical Imaging, 2024
- Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer riskEuropean Journal of Radiology, 2023
- Contrast enhanced mammography in breast cancer surveillanceBreast Cancer Research and Treatment, 2023
- Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatmentBreast Cancer Research and Treatment, 2023
- Performance of screening MRI in high risk patients at initial versus subsequent screenClinical Imaging, 2020
- Digital mammography screening: sensitivity of the programme dependent on breast densityEuropean Radiology, 2016
- The development of interval breast malignancies in patients with BRCA mutationsCancer, 2004
- A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammographyInternational Journal of Cancer, 2002